Supplementary materials for "Skin toxicities and treatment interruptions associated with epidermal growth factor receptor tyrosine kinase inhibitors"

Supplementary materials for "Skin toxicities and treatment interruptions associated with epidermal growth factor receptor tyrosine kinase inhibitors" 1) Supplementary Materials and Method 2) Supplementary Tables (Supplementary Table 1, 2, and 3) 2-1) Supplementary table 1 2-2) Supplementary table 2 2-3) Supplementary table 3